30.12.2012 Views

The Staphylococcus aureus secretome - TI Pharma

The Staphylococcus aureus secretome - TI Pharma

The Staphylococcus aureus secretome - TI Pharma

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Chapter 7<br />

Materials and Methods<br />

Bacterial strains, plasmids and growth media<br />

<strong>The</strong> bacterial strains and plasmids used in this study are listed in Table 1.<br />

Table 1. Strains and plasmids used in this study<br />

Plasmids Relevant properties Reference<br />

pDG783 pSB118 derivative; contains the kanamycin resistance marker<br />

from Streptococcus faecalis; Amp R ; Km R<br />

(Guérout-Fleury et<br />

al., 1995)<br />

pUC18 Ap R , ColE1, φ80lacZ, lac promoter (Sambrook et al.,<br />

1989)<br />

pX Vector for the integration of genes in the amyE locus of B.<br />

subtilis; integrated genes will be transcribed from the xylose<br />

inducible xylA promoter; carries the xylR gene; Amp R ; Cm R<br />

(Kim et al., 1996)<br />

pXTC pX derivative in which the chloramphenicol resistance marker<br />

has been replaced with a tetracycline resistance marker; Amp R (Darmon et al.,<br />

; 2006)<br />

Tet R<br />

TOPO pCR®-Blunt II-TOPO® vector; Km R Invitrogen Life<br />

Technologies, Inc.<br />

pMAD shuttle vector for E. coli and S. <strong>aureus</strong> with thermosensitive ori<br />

in S. <strong>aureus</strong>; contains the bgaB gene; Em R ; Amp R<br />

(Arnaud et al., 2004)<br />

pMAD-mscL pMAD plasmid with the flanking regions of S. <strong>aureus</strong> mscL;<br />

Em R ; Amp R<br />

This work<br />

BaSysBio II Ligation-independent cloning vector based on pDG1727 for<br />

Promoter-GFP activity analysis; Amp R , Spec R<br />

Stéphane Aymerich<br />

et al., unpublished<br />

Strains<br />

E. coli<br />

Genotype Reference<br />

DH5α F - , Ф80dlacZ ∆M15 endA1 recA1 gyrA96 thi-1 hsdR17 (rk- Invitrogen Life<br />

mk+) supE44 relA1 deoR ∆(lacZYA-argF) U169<br />

Technologies, Inc.<br />

TOP10 Cloning host for TOPO vector; F - mcrA ∆(mrr-hsdRMS-mcrBC)<br />

Φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(ara-leu)7697 galU<br />

galK rpsL (Str R Invitrogen Life<br />

B. subtilis<br />

) endA1 nupG<br />

Technologies, Inc.<br />

168 trpC2 (Kunst et al., 1997)<br />

168 Cm trpC2; amyE::pX; Cm R<br />

(Dubois et al., 2009)<br />

∆SPβ trpC2; ∆SPβ; sublancin 168 sensitive (Dorenbos et al.,<br />

2002)<br />

∆SPβ Tc trpC2; ∆SPβ; amyE::pXTC; sublancin 168 sensitive; Tet R<br />

(Dubois et al., 2009)<br />

∆mscL trpC2; pMU<strong>TI</strong>N4mcs::mscL; double crossover deletion of mscL;<br />

Em R<br />

BSFA collection<br />

strain BFS1257<br />

∆SPβ∆mscL trpC2; ∆SPβ; pMU<strong>TI</strong>N4mcs::mscL; Em R This work<br />

Strains<br />

B. subtilis<br />

Genotype Reference<br />

∆sunA-<br />

∆yolF<br />

trpC2; ∆yolF; ∆sunA; Km R (Dubois et al., 2009)<br />

∆sunA trpC2; ∆sunA; Km R S. <strong>aureus</strong><br />

(Dubois et al., 2009)<br />

RN4220 Restriction-deficient derivative of NCTC 8325, cured of all (Kreiswirth et al.,<br />

known prophages; rsbU-; agr-<br />

1983)<br />

RN4220 RN4220 that contains the pMAD vector for erythromycin<br />

Em resistance; Em R<br />

This work<br />

RN4220<br />

∆mscL<br />

RN4220 derivative; rsbU-; agr-; ∆mscL This work<br />

134

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!